Skip to content

AVXL - ANAVEX LIFE SCIENCES CORP. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Anavex Life Sciences Corp

AVXL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AVXLAnavex Life Sciences Corp

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $10.40
52-wk low: $2.26
Prev close: $6.53
Mkt cap: $314.2M
Fwd P/E: 3.9x
Beta: 1.14

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$42.5M

TS
Two Sigma
Q2 2026 13F
$7.9M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Jul 30, 2026

Earnings came in $0.08 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 3.85
Market cap: $314M

Valuation

P/B2.44

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AVXL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $314.24M
Beta: 1.14

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.4x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-30.8%

$2.5M

position

MW

Marshall Wace

Q2 2026 13F

$2.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for AVXL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.16-$0.08

-$0.08 expected

Next report

What the street expects next

EPS expected

-$0.11

-$0.11 to -$0.11

Revenue expected

$0.00

1 analysts

Last 30 days

2up0down

Analysts raising estimates

Estimate drift

0.01

Change in 30 days

-30.8%

ROA-19.5%

Growth

Beta1.14